Longevity Biotech

About:

Longevity Biotech develops a new class of therapeutics via artificial protein technology that focuses on pharmaceutical preparation.

Website: http://www.longevitybiotech.com

Top Investors: National Science Foundation, National Multiple Sclerosis Society (NMSS), The Thiel Foundation, Breakout Labs

Description:

Longevity Biotech, a Philadelphia, PA-based developer of a new class of therapeutics via artificial protein technology. Founded in 2010 by President Mr. Scott Shandler, Longevity Biotech focuses on pharmaceutical preparation. Its hybridtides are targeted biologic-like molecules which are highly-resistant to breakdown by natural digestive enzymes and tunable to very stable molecular structures.